StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $443.48MP/E –Yield –

Vireo Growth profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Vireo Growth's profit margin for the twelve months ending Sep 30, 2026 was -9.6%. For fiscal 2025 it was -25.3%, against -28.2% the year before. The highest annual figure on record is -25.3% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-25.3%+2.8
FY2024Dec 31, 2024-28.2%+0.8
FY2023Dec 31, 2023-29.0%+27.9
FY2022Dec 31, 2022-56.9%+5.0
FY2021Dec 31, 2021-61.9%−15.3
FY2020Dec 31, 2020-46.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-9.5%+19.2
Q2 FY2026Jun 30, 2026-0.0%+30.9
Q1 FY2026Mar 31, 2026-19.1%+7.4
Q4 FY2025Dec 31, 2025-19.5%+43.2
Q3 FY2025Sep 30, 2025-28.7%−9.1
Q2 FY2025Jun 30, 2025-31.0%−28.3
Q1 FY2025Mar 31, 2025-26.5%+1.3
Q4 FY2024Dec 31, 2024-62.7%−43.8
Q3 FY2024Sep 30, 2024-19.6%+1.6
Q2 FY2024Jun 30, 2024-2.7%+33.6
Q1 FY2024Mar 31, 2024-27.9%+16.2
Q4 FY2023Dec 31, 2023-19.0%+50.8
Q3 FY2023Sep 30, 2023-21.2%+23.5
Q2 FY2023Jun 30, 2023-36.3%−7.0
Q1 FY2023Mar 31, 2023-44.0%+49.1
Q4 FY2022Dec 31, 2022-69.8%+24.9
Q3 FY2022Sep 30, 2022-44.7%+6.7
Q2 FY2022Jun 30, 2022-29.3%+20.0
Q1 FY2022Mar 31, 2022-93.1%−41.0
Q4 FY2021Dec 31, 2021-94.7%−76.4
Q3 FY2021Sep 30, 2021-51.4%−75.1
Q2 FY2021Jun 30, 2021-49.3%+82.7
Q1 FY2021Mar 31, 2021-52.1%+9.9
Q4 FY2020Dec 31, 2020-18.3%–
Q3 FY2020Sep 30, 202023.7%–
Q2 FY2020Jun 30, 2020-131.9%–
Q1 FY2020Mar 31, 2020-62.0%–

More Vireo Growth figures

See a number that looks wrong?